Fresenius Medical Care AG (FMS) EBIAT (2016 - 2025)
Historic EBIAT for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $382.7 million.
- Fresenius Medical Care AG's EBIAT rose 3199.52% to $382.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 6217.0%. This contributed to the annual value of $791.8 million for FY2024, which is 53.85% up from last year.
- Latest data reveals that Fresenius Medical Care AG reported EBIAT of $382.7 million as of Q3 2025, which was up 3199.52% from $308.2 million recorded in Q2 2025.
- In the past 5 years, Fresenius Medical Care AG's EBIAT registered a high of $854.1 million during Q1 2025, and its lowest value of $574811.3 during Q4 2024.
- In the last 5 years, Fresenius Medical Care AG's EBIAT had a median value of $259.5 million in 2024 and averaged $252.2 million.
- Its EBIAT has fluctuated over the past 5 years, first soared by 3999093.69% in 2023, then crashed by 9979.13% in 2024.
- Fresenius Medical Care AG's EBIAT (Quarter) stood at $1.1 million in 2021, then plummeted by 38.04% to $687039.6 in 2022, then soared by 39990.94% to $275.4 million in 2023, then plummeted by 99.79% to $574811.3 in 2024, then surged by 66475.24% to $382.7 million in 2025.
- Its EBIAT stands at $382.7 million for Q3 2025, versus $308.2 million for Q2 2025 and $854.1 million for Q1 2025.